Is It Time To Consider Buying Hubbell Incorporated (NYSE:HUBB)?

Hubbell Incorporated (NYSE:HUBB), might not be a large cap stock, but it saw a significant share price rise of over 20% in the past couple of months on the NYSE. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s examine Hubbell’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Check out our latest analysis for Hubbell

Advertisement

What's the opportunity in Hubbell?

According to my valuation model, Hubbell seems to be fairly priced at around 10.42% above my intrinsic value, which means if you buy Hubbell today, you’d be paying a relatively fair price for it. And if you believe the company’s true value is $131.24, there’s only an insignificant downside when the price falls to its real value. So, is there another chance to buy low in the future? Given that Hubbell’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

What kind of growth will Hubbell generate?

earnings-and-revenue-growth
NYSE:HUBB Earnings and Revenue Growth September 1st 2020

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 23% over the next couple of years, the future seems bright for Hubbell. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? HUBB’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on HUBB, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you'd like to know more about Hubbell as a business, it's important to be aware of any risks it's facing. While conducting our analysis, we found that Hubbell has 1 warning sign and it would be unwise to ignore this.

If you are no longer interested in Hubbell, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

When trading Hubbell or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


Valuation is complex, but we're here to simplify it.

Discover if Hubbell might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
1910
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
20

About NYSE:HUBB

Hubbell

Manufactures and sells electrical and utility solutions in the United States and internationally.

Good value average dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.5% undervalued
40 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5861.4% undervalued
62 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.1% undervalued
68 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11632.1% undervalued
14 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

KE
EPICON logo
ketchup2121 on Epicon Berhad ·

From Contractor to Larger Construction Platform: Epicon's Next Phase Is Taking Shape

Fair Value:RM 0.5158.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
EPICON logo
Anthony_Lee on Epicon Berhad ·

Epicon's Q2 Recovery Shows Better Earnings Quality, With Bigger Catalysts Ahead

Fair Value:RM 0.5158.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JO
John_Eric
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8753.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
363 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9122.3% overvalued
211 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.1% undervalued
125 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative